UpdatesGeneral Updates
Syncom Formulations reported strong Q1 results: total income rose 8% to ₹133.36 Cr, and PAT surged 58% to ₹24.85 Cr.
Syncom Formulations (India) LimitedSYNCOMF · Filed with the exchange
The Board proposes a ₹0.10 per share final dividend for FY26. Growth is driven by its ethical, prescription-led model and expanding market presence.
No comments yet. Be the first.